Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancer
Authors
Keywords
-
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Volume 1869, Issue 7, Pages 119253
Publisher
Elsevier BV
Online
2022-03-05
DOI
10.1016/j.bbamcr.2022.119253
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identifying temporal and spatial patterns of variation from multimodal data using MEFISTO
- (2022) Britta Velten et al. NATURE METHODS
- Hallmarks of Cancer: New Dimensions
- (2022) Douglas Hanahan Cancer Discovery
- The growth of siRNA-based therapeutics: updated clinical studies
- (2021) M. May Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Generation and functional characterization of a single-chain variable fragment (scFv) of the anti-FGF2 3F12E7 monoclonal antibody
- (2021) Rodrigo Barbosa de Aguiar et al. Scientific Reports
- It's time to die: BH3 mimetics in solid tumors
- (2021) Sarah Kehr et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
- (2021) Zowi R. Huinen et al. Nature Reviews Clinical Oncology
- Role of bFGF in Acquired Resistance upon Anti-VEGF Therapy in Cancer
- (2021) Fatema Tuz Zahra et al. Cancers
- Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling
- (2021) Harriet R. Ferguson et al. Cells
- Cell death as a result of calcium signaling modulation: A cancer-centric prospective
- (2021) Alberto Danese et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells
- (2021) Tao Jia et al. BMC BIOLOGY
- Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics
- (2021) Sophia K. Longo et al. NATURE REVIEWS GENETICS
- Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair
- (2021) Yu Zhang et al. ONCOGENE
- The cancer angiogenesis co-culture assay: In vitro quantification of the angiogenic potential of tumoroids
- (2021) Sarah Line Bring Truelsen et al. PLoS One
- Cellular Mechanisms of FGF-Stimulated Tissue Repair
- (2021) Igor Prudovsky Cells
- Efficacy and Selectivity of FGF2-Saporin Cytosolically Delivered by PCI in Cells Overexpressing FGFR1
- (2021) Aurora K. Vikan et al. Cells
- Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
- (2021) Patrycja Szybowska et al. Cells
- Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy
- (2020) Kenji Ichikawa et al. Scientific Reports
- Visualizing and interpreting cancer genomics data via the Xena platform
- (2020) Mary J. Goldman et al. NATURE BIOTECHNOLOGY
- Acquired FGFR and FGF alterations confer resistance to estrogen receptor (ER) targeted therapy in ER+ metastatic breast cancer
- (2020) Pingping Mao et al. CLINICAL CANCER RESEARCH
- Exploring a peptidomimetic approach of N-cadherin in modulating fibroblast growth factor receptor signaling for corneal endothelial regeneration
- (2020) Chien-Chia Su et al. FASEB JOURNAL
- A collagen Vα1-derived fragment inhibits FGF-2 induced-angiogenesis by modulating endothelial cells plasticity through its heparin-binding site
- (2020) Tao Jia et al. MATRIX BIOLOGY
- Cell Death in the Origin and Treatment of Cancer
- (2020) Andreas Strasser et al. MOLECULAR CELL
- FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
- (2020) Jae Hong Im et al. Nature Communications
- Long-Pentraxin 3 Affects Primary Cilium in Zebrafish Embryo and Cancer Cells via the FGF System
- (2020) Jessica Guerra et al. Cancers
- The hallmarks of cancer are also the hallmarks of wound healing
- (2020) Lucy MacCarthy-Morrogh et al. Science Signaling
- Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation
- (2020) De-Li ZhuGe et al. ARCHIVES OF PHARMACAL RESEARCH
- Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
- (2020) Melanie A. Krook et al. BRITISH JOURNAL OF CANCER
- Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer
- (2020) Nourhan Hassan et al. CELLULAR SIGNALLING
- Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
- (2019) Rumani Singh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma
- (2019) Emilie M. J. van Brummelen et al. INVESTIGATIONAL NEW DRUGS
- The Calcium-Signaling Toolkit in Cancer: Remodeling and Targeting
- (2019) Sarah J. Roberts-Thomson et al. Cold Spring Harbor Perspectives in Biology
- Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
- (2019) Sana Raoof et al. ONCOGENE
- CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond
- (2019) Marcelo G. Kazanietz et al. Frontiers in Endocrinology
- Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant
- (2019) Pino Bordignon et al. Cell Reports
- The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach
- (2019) Rezzola et al. Cancers
- Vessel co-option in glioblastoma: emerging insights and opportunities
- (2019) Giorgio Seano et al. ANGIOGENESIS
- An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
- (2019) Daniel Morgensztern et al. LUNG CANCER
- Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
- (2019) Alexandru Andrei Tirpe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- FGF2 and EGF induce epithelial–mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal
- (2018) Karin Schelch et al. CARCINOGENESIS
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
- (2018) Joao Incio et al. Science Translational Medicine
- Construction of a human monoclonal antibody against bFGF for suppression of NSCLC
- (2018) Sheng Wang et al. Journal of Cancer
- Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway in KRAS-mutant non-small cell lung cancer
- (2018) Eric Haines et al. Oncotarget
- Fibroblast growth factor receptors as treatment targets in clinical oncology
- (2018) Masaru Katoh Nature Reviews Clinical Oncology
- SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilities
- (2017) Catherine E. Dominguez et al. HUMAN GENETICS
- Production of bFGF monoclonal antibody and its inhibition of metastasis in Lewis lung carcinoma
- (2017) Yanqing Yang et al. Molecular Medicine Reports
- FGF-dependent metabolic control of vascular development
- (2017) Pengchun Yu et al. NATURE
- Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer
- (2017) D Chakraborty et al. ONCOGENE
- siRNA-mediated silencing of bFGF gene inhibits the proliferation, migration, and invasion of human pituitary adenoma cells
- (2017) Kai Zhou et al. TUMOR BIOLOGY
- Blocking FGF2 with a new specific monoclonal antibody impairs angiogenesis and experimental metastatic melanoma, suggesting a potential role in adjuvant settings
- (2016) Rodrigo Barbosa de Aguiar et al. CANCER LETTERS
- FGFR1 Induces Glioblastoma Radioresistance through the PLC /Hif1 Pathway
- (2016) V. Gouaze-Andersson et al. CANCER RESEARCH
- N-Cadherin and Fibroblast Growth Factor Receptors crosstalk in the control of developmental and cancer cell migrations
- (2016) Thao Nguyen et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Identification of new FGF1 binding partners-Implications for its intracellular function
- (2016) Joanna Bober et al. IUBMB LIFE
- Bcl-2 proteins and calcium signaling: complexity beneath the surface
- (2016) T Vervliet et al. ONCOGENE
- Blocking the FGF/FGFR system as a ⿿two-compartment⿿ antiangiogenic/antitumor approach in cancer therapy
- (2016) Arianna Giacomini et al. PHARMACOLOGICAL RESEARCH
- bFGF Promotes Migration and Induces Cancer-Associated Fibroblast Differentiation of Mouse Bone Mesenchymal Stem Cells to Promote Tumor Growth
- (2016) Xue Yang et al. STEM CELLS AND DEVELOPMENT
- Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
- (2016) Mohamed R. Akl et al. Oncotarget
- Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors
- (2016) Chiara Foglieni et al. Scientific Reports
- A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors
- (2015) A. W. Tolcher et al. ANNALS OF ONCOLOGY
- Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab
- (2015) Atsushi Mitsuhashi et al. Nature Communications
- FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors
- (2015) F. Li et al. Cancer Discovery
- API5 Confers Tumoral Immune Escape through FGF2-Dependent Cell Survival Pathway
- (2014) K. H. Noh et al. CANCER RESEARCH
- The FGFR/MEK/ERK/brachyury pathway is critical for chordoma cell growth and survival
- (2014) Yunping Hu et al. CARCINOGENESIS
- Immobile survival of motoneuron (SMN) protein stored in Cajal bodies can be mobilized by protein interactions
- (2013) Benjamin Förthmann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CXCL4L1–fibstatin cooperation inhibits tumor angiogenesis, lymphangiogenesis and metastasis
- (2013) A.C. Prats et al. MICROVASCULAR RESEARCH
- A Proangiogenic Signature Is Revealed in FGF-Mediated Bevacizumab-Resistant Head and Neck Squamous Cell Carcinoma
- (2013) R. Gyanchandani et al. MOLECULAR CANCER RESEARCH
- Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells
- (2013) Man-Tat Lau et al. PLoS One
- Identification and Characterization of FGF2-Dependent mRNA: microRNA Networks During Lens Fiber Cell Differentiation
- (2013) Louise Wolf et al. G3-Genes Genomes Genetics
- A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
- (2013) K E Ware et al. Oncogenesis
- A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts
- (2012) L. Wang et al. MOLECULAR CANCER THERAPEUTICS
- Structural and Functional Integration of the PLCγ Interaction Domains Critical for Regulatory Mechanisms and Signaling Deregulation
- (2012) Tom D. Bunney et al. STRUCTURE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
- (2011) Rachel Sharpe et al. CLINICAL CANCER RESEARCH
- Delayed cell death associated with mitotic catastrophe in γ-irradiated stem-like glioma cells
- (2011) Elke Firat et al. Radiation Oncology
- Change in fibroblast growth factor 2 expression as an early phase radiotherapy-responsive marker in sequential biopsy samples from patients with cervical cancer during fractionated radiotherapy
- (2010) Miyako Nakawatari et al. CANCER
- Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors
- (2010) Giorgio Colombo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adenovirus-mediated delivery of bFGF small interfering RNA increases levels of connexin 43 in the glioma cell line, U251
- (2010) Biao Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
- (2010) E. M. Haugsten et al. MOLECULAR CANCER RESEARCH
- New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2
- (2009) Laura Ragona et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
- (2009) Christopher G. Willett et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
- (2009) Scott Kopetz et al. JOURNAL OF CLINICAL ONCOLOGY
- A pro-inflammatory signature mediates FGF2-induced angiogenesis
- (2008) Germán Andrés et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Non-canonical fibroblast growth factor signalling in angiogenesis
- (2007) M. Murakami et al. CARDIOVASCULAR RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now